Use of GTF21 Mutations in the Prognosis of Thymic Cancers
US Patent 9,493,842
Filed on 2015-04-02
Filed on 2015-04-02
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Hong Kong
18102573.1
Filed on 2018-02-22
18102573.1
Filed on 2018-02-22
Improved Pseudomonas Exotoxin A With Reduced Immunogenicity
Italy
10755283.8
Filed on 2010-09-10
10755283.8
Filed on 2010-09-10
Improved Pseudomonas Exotoxin A With Reduced Immunogenicity
United Kingdom
10755283.8
Filed on 2010-09-10
10755283.8
Filed on 2010-09-10
Improved Pseudomonas Exotoxin A With Reduced Immunogenicity
France
10755283.8
Filed on 2010-09-10
10755283.8
Filed on 2010-09-10
Improved Pseudomonas Exotoxin A With Reduced Immunogenicity
Spain
10755283.8
Filed on 2010-09-10
10755283.8
Filed on 2010-09-10
Improved Pseudomonas Exotoxin A With Reduced Immunogenicity
Germany
10755283.8
Filed on 2010-09-10
10755283.8
Filed on 2010-09-10
Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases
United Kingdom
11711417.3
Filed on 2012-09-11
11711417.3
Filed on 2012-09-11
Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases
France
11711417.3
Filed on 2012-09-11
11711417.3
Filed on 2012-09-11